Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial-Reference-Cited by-同舟云学术

Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial

Published:2010-05-06 Issue:6 Volume:40 Page:922-932
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:

Author:

Eifan A. O.,Akkoc T.,Yildiz A.,Keles S.,Ozdemir C.,Bahceciler N. N.,Barlan I. B.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2009.03448.x/fullpdf

Reference36 articles.

1. ISAAC phase three study group;Asher;Lancet,2006

2. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa;Ait-Khaled;the International Study of Asthma and Allergies in Childhood Phase III,2007

3. WHO position paper. Allergen immunotherapy;Bousquet;therapeutic vaccines for allergic diseases,1998

4. Diagnosis and treatment of asthma in childhood;Bacharier;a PRACTALL consensus report,2008

5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma;Roberts;J Allergy Clin Immunol,2006

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of subcutaneous and sublingual allergen immunotherapy in the treatment of asthma in children: a systematic review and meta-analysis;Journal of Asthma;2024-08-28

2. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

3. Preventive allergen immunotherapy with inhalant allergens in children;Allergy;2024-04-08

4. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy;Otolaryngology–Head and Neck Surgery;2024-02-26

5. Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis;Allergy;2024-02-25